Novel nikkomycins Lx and Lz produced by genetically engineered Streptomyces tendae Tü901.
Bormann
C
C
Institute of Biology II, Microbiology/Biotechnology, University of Tübingen, Germany.
Lauer
B
B
Kálmánczhelyi
A
A
Süssmuth
R
R
Jung
G
G
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents / Q000096:biosynthesis* / Q000737:chemistry / Q000494:pharmacology; D000935:Antifungal Agents / Q000096:biosynthesis* / Q000737:chemistry / Q000494:pharmacology; D002851:Chromatography, High Pressure Liquid; D005658:Fungi / Q000187:drug effects; D005818:Genetic Engineering; D006863:Hydrogen-Ion Concentration; D009682:Magnetic Resonance Spectroscopy; D015394:Molecular Structure; D009705:Nucleosides / Q000096:biosynthesis* / Q000737:chemistry / Q000494:pharmacology; D011725:Pyridines / Q000737:chemistry / Q000378:metabolism* / Q000494:pharmacology; D013302:Streptomyces / Q000235:genetics* / Q000378:metabolism*; D014498:Uracil / Q000031:analogs & derivatives* / Q000096:biosynthesis / Q000737:chemistry / Q000378:metabolism / Q000494:pharmacology
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D000935:Antifungal Agents; D009705:Nucleosides; D011725:Pyridines; C121128:nikkomycin L(x); C121129:nikkomycin L(z); D014498:Uracil; C011952:nikkomycin